Berkovic S F, Scheffer I E
Department of Medicine (Neurology), University of Melbourne, Austin & Repatriation Medical Centre, Victoria, Australia.
Brain Dev. 1997 Jan;19(1):13-8. doi: 10.1016/s0387-7604(96)00060-5.
Single gene disorders offer the best opportunity for identification of genetic linkage and of abnormal genes. Epilepsies with single gene inheritance include symptomatic epilepsies where there is associated diffuse brain dysfunction, and idiopathic epilepsies where seizures are the major neurological abnormality. There are over 200 single gene symptomatic epilepsies; most are rare. Gene identification has been achieved in a number of these conditions but these important advances have not yet led to a better understanding of epileptogenesis, because of the associated brain disease. Idiopathic single gene epilepsies include benign familial neonatal convulsions, where genetic linkage to chromosomes 20q and 8q has been found in different families, and benign familial infantile convulsions where linkage is presently unknown. Recently, four autosomal dominant partial epilepsies have been described. In autosomal dominant nocturnal frontal lobe epilepsy a genetic defect in the alpha 4 subunit of the nicotinic acetylcholine receptor was found in one family. This is the first genetic defect described in an idiopathic epilepsy. The other three syndromes are autosomal dominant partial epilepsy with variable foci, autosomal dominant rolandic epilepsy with speech dyspraxia, and familial temporal lobe epilepsy. In the latter condition, linkage to chromosome 10q has been reported in one family, but the genetic defect is unknown. It is likely that other idiopathic single gene epilepsies will be identified. Molecular genetic study of these disorders is likely to lead to discovery of other epilepsy genes. This will lead to an improved understanding of human epileptogenesis with implications for clinical diagnosis, genetic counselling, pharmacological therapy and possibly prevention of epilepsy.
单基因疾病为鉴定基因连锁和异常基因提供了最佳机会。单基因遗传的癫痫包括伴有弥漫性脑功能障碍的症状性癫痫,以及以癫痫发作作为主要神经学异常的特发性癫痫。有超过200种单基因症状性癫痫;大多数都很罕见。在其中一些疾病中已经实现了基因鉴定,但由于相关的脑部疾病,这些重要进展尚未带来对癫痫发生机制更好的理解。特发性单基因癫痫包括良性家族性新生儿惊厥(在不同家族中已发现与20号染色体长臂和8号染色体长臂存在基因连锁)以及良性家族性婴儿惊厥(目前连锁情况未知)。最近,已经描述了四种常染色体显性遗传性部分性癫痫。在常染色体显性遗传性夜间额叶癫痫中,在一个家族中发现了烟碱型乙酰胆碱受体α4亚基的基因缺陷。这是在特发性癫痫中描述的首个基因缺陷。其他三种综合征是具有可变病灶的常染色体显性遗传性部分性癫痫、伴有言语失用症的常染色体显性遗传性罗兰多癫痫以及家族性颞叶癫痫。在后者的情况下,在一个家族中已报道与1号染色体长臂存在连锁,但基因缺陷未知。很可能会鉴定出其他特发性单基因癫痫。对这些疾病的分子遗传学研究可能会导致发现其他癫痫基因。这将增进对人类癫痫发生机制的理解,对临床诊断、遗传咨询、药物治疗以及可能的癫痫预防都具有重要意义。